Pharmaceutical giant Pfizer has sued rival Johnson & Johnson over claims the company forced health care providers and insurers into exclusionary contracts aimed at blocking a competing autoimmune medication Pfizer recently introduced into the market.

Pfizer filed its lawsuit Wednesday in the U.S. District Court for the Eastern District of Pennsylvania, alleging J&J engaged in monopolistic conduct and violated the Sherman Antitrust Act. The lawsuit, which, according to the docket, has been assigned to Judge J. Curtis Joyner, was filed by Cozen O'Connor attorney Robert Fiebach.

The lawsuit, Pfizer v. Johnson & Johnson, stems from Pfizer's rollout of its generic version of an infusion therapy treatment for rheumatoid arthritis, plaque psoriasis and Crohn's disease.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Go To Lexis →

Not a Lexis Subscriber?
Subscribe Now

Go To Bloomberg Law →

Not a Bloomberg Law Subscriber?
Subscribe Now

NOT FOR REPRINT